Funding for this research was provided by:
Lupus Research Alliance (519414)
National Center for Advancing Translational Sciences (UL1 TR002319)
Greta och Johan Kocks stiftelser
Received: 17 April 2020
Accepted: 19 May 2020
First Online: 29 May 2020
Ethics approval and consent to participate
: The study was approved by the regional ethics boards (LU06014520 and LU 378-02). Informed written consent was obtained from all participants according to the Declaration of Helsinki.
: Not applicable
: CL holds a patent pending for the IC-FLOW technology. The other authors (AAB, HT) declare no conflicts of interest.